載入...
Endocrine side effects of broad-acting kinase inhibitors
Targeted therapy in oncology consists of drugs that specifically interfere with abnormal signaling pathways that are dysregulated in cancer cells. Tyrosine kinase inhibitors (TKIs) take advantage of unique oncogenes that are activated in certain types of cancer, and also target common mechanisms of...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3039175/ https://ncbi.nlm.nih.gov/pubmed/20603395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1677/ERC-10-0082 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|